Evidence map›Paper›PMID 35577499›Full record

ArticleRevista espanola de medicina nuclear e imagen molecular

Possible role of

Nicoletta Urbano, Manuel Scimeca, Rita Bonfiglio, Elena Bonanno, Orazio Schillaci

Open access · greenAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Revista espanola de medicina nuclear e imagen molecular. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Nicoletta UrbanoNuclear Medicine Unit, Department of Oncohaematology, Policlinico "Tor Vergata", Rome, Italy.
Manuel ScimecaDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, Rome 00133, Italy; San Raffaele University, Via di Val Cannuta 247, 00166, Rome, RM, Italy; Saint Camillus International University of Health Sciences, Via di Sant'Alessandro, 8, 00131 Rome, RM, Italy. Electronic address: manuel.scimeca@uniroma2.it.
Rita BonfiglioDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, Rome 00133, Italy.
Elena BonannoDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, Rome 00133, Italy.
Orazio SchillaciDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, Rome 00133, Italy; IRCCS Neuromed, Via Atinense, 18, 8607 Pozzilli, IS, Italy.
University of Rome Tor Vergata · ITIstituto Neurologico Mediterraneo · ITPoliclinico Tor Vergata · ITSan Raffaele University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SARS-CoV-2Follow-Up StudiesHumansRadionuclide ImagingTechnetium Tc 99m SestamibiTechnetium Tc 99m Sestamibi

Identifiers

PMID35577499
PMCPMC7945867
OpenAlexW3136306808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.